Juxtaglomerular cell complex in the regulation of renal salt excretion
- PMID: 9486281
- DOI: 10.1152/ajpregu.1998.274.2.R263
Juxtaglomerular cell complex in the regulation of renal salt excretion
Abstract
Luminal NaCl concentration at the macula densa (MD) has the two established effects of regulating glomerular arteriolar resistance and renin secretion. Tubuloglomerular feedback (TGF), the inverse relationship between MD NaCl concentration and glomerular filtration rate (GFR), stabilizes distal salt delivery and thereby NaCl excretion in response to random perturbations unrelated to changes in body salt balance. Control of vasomotor tone by TGF is exerted primarily by NaCl transport-dependent changes in local adenosine concentrations. During long-lasting perturbations of MD NaCl concentration, control of renin secretion becomes the dominant function of the MD. The potentially maladaptive effect of TGF under chronic conditions is prevented by TGF adaptations, permitting adjustments in GFR to occur. TGF adaptation is mechanistically coupled to the end point targeted by chronic deviations in MD NaCl, the rate of local and systemic angiotensin II generation. MD control of renin secretion is the result of the coordinated action of local mediators that include nitric oxide synthase (NOS) and cyclooxygenase (COX) products. Thus vascular smooth muscle cell activation during high MD transport and granular cell activation during low MD transport is achieved by different extracellular mediators. The coordinated regulation of NOS I and COX-2 expression in MD cells and of renin expression in granular cells suggests that control of juxtaglomerular regulation of gene transcription or mRNA metabolism may be another consequence of a chronic alteration in MD NaCl concentration.
Similar articles
-
Tubuloglomerular feedback: new concepts and developments.Kidney Int Suppl. 1998 Sep;67:S40-5. doi: 10.1046/j.1523-1755.1998.06708.x. Kidney Int Suppl. 1998. PMID: 9736251 Review.
-
Temporal adaptation of tubuloglomerular feedback: effects of COX-2.Kidney Int. 2004 Dec;66(6):2348-53. doi: 10.1111/j.1523-1755.2004.66033.x. Kidney Int. 2004. PMID: 15569325
-
Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2.Am J Physiol. 1999 Nov;277(5):F706-10. doi: 10.1152/ajprenal.1999.277.5.F706. Am J Physiol. 1999. PMID: 10564233
-
Cyclooxygenase-2 and the renal renin-angiotensin system.Acta Physiol Scand. 2004 Aug;181(4):543-7. doi: 10.1111/j.1365-201X.2004.01329.x. Acta Physiol Scand. 2004. PMID: 15283769 Review.
-
Cellular mechanisms within the juxtaglomerular apparatus.Am J Hypertens. 1990 Jan;3(1):76-80. doi: 10.1093/ajh/3.1.76. Am J Hypertens. 1990. PMID: 2405885 Review.
Cited by
-
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.Pediatr Nephrol. 2011 Oct;26(10):1789-802. doi: 10.1007/s00467-011-1871-4. Epub 2011 Apr 19. Pediatr Nephrol. 2011. PMID: 21503667 Free PMC article. Review.
-
Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.Circulation. 2020 Sep 15;142(11):1028-1039. doi: 10.1161/CIRCULATIONAHA.120.045691. Epub 2020 May 15. Circulation. 2020. PMID: 32410463 Free PMC article. Clinical Trial.
-
Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond.Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):23. doi: 10.1007/s11936-017-0522-x. Curr Treat Options Cardiovasc Med. 2017. PMID: 28299616 Review.
-
SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.Curr Heart Fail Rep. 2017 Aug;14(4):331-337. doi: 10.1007/s11897-017-0345-9. Curr Heart Fail Rep. 2017. PMID: 28667491 Review.
-
Management of Cardio-Renal Syndrome and Diuretic Resistance.Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):11. doi: 10.1007/s11936-015-0436-4. Curr Treat Options Cardiovasc Med. 2016. PMID: 26803318
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials